Bausch + Lomb Corp shares have seen a slight decline in recent trading sessions, reflecting broader market sentiments alongside notable company developments.
Bausch + Lomb Corp (BLCO.TO) has experienced a 3.00% drop in its stock price over the past week, closing at C$23.49. This follows the announcement of significant advancements in their product offerings, especially in laser technology. As the company implements its growth strategies, investors are closely watching market reactions and performance indicators.
Advertisement
Bausch + Lomb Corp
BLCO.TO
BLCO.TO
Bausch + Lomb Corp
WealthAwesomeMarket cap
$8.80B
52W high
$25.70
52W low
$20.25
1W change
+4.13%
Beta
0.56
Analyst Price Targets
Based on analyst covering BLCO · as of Oct 28, 2026
Wall Street analysts forecast BLCO stock price to rise 1.3% over the next 12 months.
Consensus
NeutralBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$25.05
+1.3% Upside
Previously C$25.01 on Oct 26, 2026
Current Price
C$24.72
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BLCO's historical volatility
30-Day Vol
35.1%
Annualized
90-Day Vol
31.0%
Annualized
Trend (90d)
+16.6%
Annualized drift
90d Mean
C$26.23
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$25.21 | C$22.34 – C$28.46 |
| 60 trading days | C$25.72 | C$21.67 – C$30.52 |
| 90 trading days | C$26.23 | C$21.27 – C$32.35 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: While Bausch + Lomb's recent product approvals suggest potential growth, the stock's performance indicates investor caution amid broader market conditions. Investors should weigh the company's innovations against its current financial metrics when assessing future prospects.
C$23.49
Bausch + Lomb's stock closed at C$23.49, reflecting a modest decline of 0.21% on the day amid mixed market signals.
Bull case
The recent CE Mark approvals for Bausch + Lomb's SeeLyra™ Femtosecond Laser could give the company a competitive edge in the medical technology market, potentially leading to increased market share and revenue growth.
Bear case
Despite these positive developments, the company's negative profit margins and declining stock price over the past week may raise concerns about its short-term financial health and investor sentiment.
Recent Price Action
Bausch + Lomb Corp (BLCO.TO) closed at C$23.49, marking a slight decline of 0.21% for the day. Over the past week, the stock has decreased by 3.00%, while it has shown a modest increase of 1.75% over the last month. Year-to-date, the stock is up by 4.87%, indicating some resilience despite recent fluctuations.
Company News and Catalysts
Advertisement
Bausch + Lomb recently received European CE Mark approval for its next-generation SeeLyra™ Femtosecond Laser, a significant advancement that could enhance its product portfolio in the competitive medical technology market. This announcement, along with a recent award received by Robinson Pharma, Inc. for its partnership with Bausch + Lomb, underscores the company's ongoing commitment to innovation and collaboration in the healthcare sector.
Technical Picture
From a technical standpoint, Bausch + Lomb's stock is currently trading slightly below its 50-day moving average of C$23.58, indicating potential short-term weakness. The 200-day moving average stands at C$22.96, suggesting a more stable long-term trend. The stock has a beta of 0.56, indicating lower volatility compared to the broader market. The 52-week range for BLCO.TO is between C$19.36 and C$25.70, with the current price at approximately 65% of this range. Volume has been low, with the latest trading volume at 806 shares, significantly below the 20-day average of 1,789 shares, reflecting reduced investor activity.
Insider Activity
No recent insider activity has been reported for Bausch + Lomb Corp, indicating that there have not been significant changes in insider ownership or trading that might influence investor sentiment.
Final Thoughts
Bausch + Lomb Corp closed at C$23.49, down 0.21% for the day. Investors should keep an eye on the company's ongoing product developments and market positioning as they navigate current market conditions.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
